Business Description
Theratechnologies Inc
NAICS : 541714
SIC : 3741
ISIN : CA88338H7040
Description
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.67 | |||||
| Equity-to-Asset | -0.28 | |||||
| Debt-to-Equity | -2.94 | |||||
| Debt-to-EBITDA | 4.99 | |||||
| Interest Coverage | 0.92 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -6.13 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.7 | |||||
| 3-Year EBITDA Growth Rate | 4.9 | |||||
| 3-Year EPS without NRI Growth Rate | 8.6 | |||||
| 3-Year FCF Growth Rate | 25 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.61 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.3 | |||||
| 9-Day RSI | 45.58 | |||||
| 14-Day RSI | 48.39 | |||||
| 6-1 Month Momentum % | -9.4 | |||||
| 12-1 Month Momentum % | 23.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.08 | |||||
| Quick Ratio | 0.97 | |||||
| Cash Ratio | 0.73 | |||||
| Days Inventory | 114.82 | |||||
| Days Sales Outstanding | 47.21 | |||||
| Days Payable | 439.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.7 | |||||
| Shareholder Yield % | 8.31 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.99 | |||||
| Operating Margin % | 11.83 | |||||
| Net Margin % | -3.7 | |||||
| FCF Margin % | -5.47 | |||||
| ROA % | -4.51 | |||||
| ROIC % | 32.78 | |||||
| 3-Year ROIIC % | -68.81 | |||||
| ROC (Joel Greenblatt) % | 571.35 | |||||
| ROCE % | 93.52 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 10.47 | |||||
| PS Ratio | 0.65 | |||||
| EV-to-EBIT | 8.87 | |||||
| EV-to-EBITDA | 6.7 | |||||
| EV-to-Revenue | 0.92 | |||||
| EV-to-Forward-Revenue | 0.88 | |||||
| EV-to-FCF | -17.22 | |||||
| Price-to-Median-PS-Value | 0.15 | |||||
| Earnings Yield (Greenblatt) % | 11.27 | |||||
| FCF Yield % | -7.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Theratechnologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 77.595 | ||
| EPS (TTM) (€) | -0.049 | ||
| Beta | -1.4 | ||
| Volatility % | 100.49 | ||
| 14-Day RSI | 48.39 | ||
| 14-Day ATR (€) | 0.028464 | ||
| 20-Day SMA (€) | 1.1075 | ||
| 12-1 Month Momentum % | 23.26 | ||
| 52-Week Range (€) | 0.78 - 2.1 | ||
| Shares Outstanding (Mil) | 45.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Theratechnologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Theratechnologies Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Theratechnologies Inc Frequently Asked Questions
What is Theratechnologies Inc(STU:TQ80)'s stock price today?
The current price of STU:TQ80 is €1.11. The 52 week high of STU:TQ80 is €2.10 and 52 week low is €0.78.
When is next earnings date of Theratechnologies Inc(STU:TQ80)?
The next earnings date of Theratechnologies Inc(STU:TQ80) is 2025-02-21 Est..
Does Theratechnologies Inc(STU:TQ80) pay dividends? If so, how much?
Theratechnologies Inc(STU:TQ80) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers